WHO model list of essential in vitro diagnostics information
World Health Organization (WHO) priority list of medical tests
For the lists for medicines, see WHO Model List of Essential Medicines.
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (April 2023)
The WHO model list of essential in vitro diagnostics, or WHO list of essential diagnostic tests (EDL) is a World Health Organization (WHO) priority list of medical tests that provides guidance for individual countries on which tests to use and which not to.[1][2] It was first published in 2018,[1][3] then revised in 2019,[1][3] and a third edition was published in 2020.[1][4]
Tests in community settings where there is no laboratory, are divided into general tests and tests that are disease-specific.[5] Diseases that can be tested for in the community without laboratory facilities include: Chagas disease, cholera, COVID-19, diabetes mellitus, hepatitis B and C, HIV, influenza, malaria, Streptococcal pharyngitis, sickling disorders, syphilis, tuberculosis and visceral leishmaniasis.[5] Where there is a health care facility with laboratories, tests are divided into either general tests or disease-specific tests for clinical laboratories, and disease-specific tests for blood screening laboratories.[5] For each group of tests, the EDL specifies the test's name, purpose, assay format and type of specimen.[6]
^ abcdBernabé-Ortiz, Antonio; Zafra-Tanaka, Jessica H.; Moscoso-Porras, Miguel; Sampath, Rangarajan; Vetter, Beatrice; Miranda, J. Jaime; Beran, David (9 March 2021). "Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response". Globalization and Health. 17 (1): 26. doi:10.1186/s12992-021-00676-6. ISSN 1744-8603. PMC 7941936. PMID 33750391.
^Cite error: The named reference WHO.p.2.2020 was invoked but never defined (see the help page).
^ abCam, Yann Le. "WHO Essential Medicines and in Vitro Diagnostics Lists: Why, What & How" (PDF). Rarediseasesinternational.org. Rare Diseases International.
^The selection and use of essential in vitro diagnostics: report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential in vitro diagnostics). Geneva: World Health Organization; 2021 (WHO Technical Report Series, No. 1031). Licence: CC BY-NC-SA 3.0 IGO.
^ abc"The selection and use of essential in vitro diagnostics - 2020". www.who.int. World Health Organization. pp. 272–352. Retrieved 20 August 2021.
^"Brochure: The WHO model list of essential in vitro diagnostics (EDL)". www.who.int. 27 January 2021. Retrieved 27 August 2021.
and 28 Related for: WHO model list of essential in vitro diagnostics information
First WHOModelListofEssentialInVitroDiagnostics. Geneva: World Health Organization. hdl:10665/311567. ISBN 978-92-4-121026-3. ISSN 0512-3054. WHO Technical...
generation diagnostic platform with broad invitrodiagnostics applications, particular in the point of care area. It is developing a series of new nanofluidic...
often recognize Invitrodiagnostics as a subclass of medical devices and establish accessories as medical devices. Section 201(h) of the Federal Food...
has shown substantial effects of some FDA-approved drugs with an invitro kill rate above 90%. These results were invitro effects, but as the drugs are...
characteristics of the components of the immune system invitro, in situ, and in vivo. Immunology has applications in numerous disciplines of medicine, particularly...
use ofessential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHOModelListofEssential Medicines and 5th WHOModel List...
PMID 17021129. Stoven S, Murray JA, Marietta EV (2013). "Latest invitro and in vivo modelsof celiac disease". Expert Opin Drug Discov (Review). 8 (4): 445–57...
to emergence and reemergence of plant pathogens in horticultural Crops. Development ofDiagnostics and to offer diagnostic services to SAUs, Farmers and...
Health Organization ModelListofEssential Medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06...
technology for couples who stay childless against their will, such as fertility medication, artificial insemination, invitro fertilization and surrogacy...
selection and use ofessential medicines 2023: web annex A: World Health Organization modellistofessential medicines: 23rd list (2023). Geneva: World...
medical device, or diagnostic assay, the product candidate is tested extensively in preclinical studies. Such studies involve invitro (test tube or cell...
anti-retroviral drugs. Molecular diagnostics are now commonly used to identify HIV in healthy people long before the onset of illness and have been used to...
and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: invitro screening assays". Journal of Toxicology and Environmental Health...
selection and use ofessential medicines 2023: web annex A: World Health Organization modellistofessential medicines: 23rd list (2023). Geneva: World...
Kirby SD, Baskin SI (1989). "The inactivation of rhodanese by nitrite and inhibition by other anions invitro". J. Biochem. Toxicol. 4 (1): 29–33. doi:10...
context of a patient's genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging...
Global Information